BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 28, 2008
View Archived Issues
Genz-29155 and sirolimus combination synergistic in renal transplant model
Read More
Studies reveal neurological effects of berberine
Read More
Effects of LY-450139 on Abeta studied with novel labeling agent 13C6-leucine
Read More
Durable safety and efficacy seen with belatacept in phase II study
Read More
Studies report efficacy of alternative regimens of enteric-coated mycophenolate in transplantation
Read More
Superior characteristics of P2Y12 inhibitor PRT-060128 detailed
Read More
Novel therapeutic agents for neurological disorders divulged in recent patents
Read More
GlaxoSmithKline reports on efforts to identify GlyT-1 inhibitors for schizophrenia
Read More
Baxter enters U.S. licensing agreement for Innocoll's gentamicin surgical implant for SSIs
Read More
FDA reports two new cases of PML in patients receiving Tysabri as monotherapy for MS
Read More
Novavax presents favorable results from phase I/IIa pandemic influenza vaccine trial
Read More
New treatment options for cancer reported in recent patent literature
Read More
CE mark for Cypher Select Plus in acute myocardial infarction
Read More
Phase IIa study of CK-1827452 successfully completes interim safety analysis
Read More
Recent Novartis patent describes new agents for respiratory disorders
Read More
Cell Genesys terminates VITAL-2 GVAX trial in advanced prostate cancer
Read More
Genmab to initiate four ofatumumab studies
Read More
M2e universal influenza vaccine candidate shows safety and immunogenicity
Read More
NexMed decides not to submit NDA for NM-100060
Read More
Pain Therapeutics and King Pharmaceuticals develop a new abuse-resistant pain medication
Read More
Photocure presents positive phase II results with Visonac for acne
Read More
Protherics commences phase IIa Prolarix study in liver cancer
Read More
Algeta presents phase II data on pain palliation with alpharadin
Read More
Arana completes enrollment in phase II ART-621 trial in psoriasis
Read More
Merck and Intercell commence phase II clinical trial of V-710 in S. aureus infection
Read More